Roche's competitors

Roche's competitors include Abbott, Pfizer, Danaher, AbbVie, Bayer and Baxalta
Add company...
Roche
We are the world's number 1 in biotech with 17 biopharmaceuticals on the market.
Abbott
Abbott is a genomic disease management company that develops and markets clinical laboratory products.
Pfizer
Pfizer, a biopharmaceutical company, develops and manufactures human and veterinary medicines, as well as consumer healthcare products.
Danaher
Danaher Corporation designs, manufactures and markets professional, medical, industrial and commercial products and services.
AbbVie
AbbVie is a pharmaceutical company that discovers, develops, and markets both biopharmaceuticals and small molecule drugs.
Bayer
Bayer is a multinational pharmaceutical and life sciences company.
Baxalta
Baxalta Incorporated is a global biopharmaceutical company.
Founding Date
Founding Date
1896
Founding Date
1991
Founding Date
1848
Founding Date
1969
Founding Date
2013
Founding Date
1863
Founding Date
2014
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Subsidiary
Tags
Locations
Locations
Basel, CH HQ
South San Francisco, US
Locations
Illinois City, US HQ
Sao Paulo, BR
Québec, CA
Beijing, CN
Shanghai, CN
Wiesbaden, DE
Tokyo, JP
see more
Locations
New York, US HQ
Buenos Aires, AR
Bentley, AU
São Paulo, BR
Shanghai, CN
Ballerup, DK
Freiburg, DE
see more
Locations
Washington, US HQ
Changning, CN
Mumbai, IN
Surrey, GB
Locations
North Chicago, US HQ
Locations
Leverkusen, DE HQ
Pymble, AU
São Paulo, BR
Mississauga, CA
Shanghai, CN
Havana, CU
Guatemala, GT
see more
Locations
Illinois City, US HQ
Employees
Employees
94,052
Employees
75,000
Employees
96,500
Employees
62,000
Employees
30,000
Employees
99,845 14% decrease
Employees
2,287
Valuation ($)
Valuation ($)
N/A
Valuation ($)
105.2 b
Valuation ($)
219 b
Valuation ($)
68.8 b
Valuation ($)
190.1 b
Valuation ($)
113.3 b
Valuation ($)
N/A
Facebook followers
Facebook followers
77.9 k
Facebook followers
191.5 k
Facebook followers
312.9 k
Facebook followers
208
Facebook followers
11.7 k
Facebook followers
2.8 m
Facebook followers
N/A
Twitter followers
Twitter followers
175 k
Twitter followers
60.2 k
Twitter followers
12.9 k
Twitter followers
255
Twitter followers
47.6 k
Twitter followers
144.8 k
Twitter followers
N/A

Financial

Revenue (est.)
Revenue (est.)
Fr.48.1b (FY, 2015)
Revenue (est.)
$20.9b (FY, 2016)
Revenue (est.)
$52.8b (FY, 2016)
Revenue (est.)
$16.9b (FY, 2016)
Revenue (est.)
$25.6b (FY, 2016)
Revenue (est.)
€46.8b (FY, 2016)
Revenue (est.)
N/A
Cost of goods
Cost of goods
Fr.15.5b (FY, 2015)
Cost of goods
$9b (FY, 2016)
Cost of goods
$12.3b (FY, 2016)
Cost of goods
$7.5b (FY, 2016)
Cost of goods
$5.8b (FY, 2016)
Cost of goods
€20.3b (FY, 2016)
Cost of goods
N/A
Gross profit
Gross profit
Fr.32.7b (FY, 2015)
Gross profit
$11.8b (FY, 2016)
Gross profit
$40.5b (FY, 2016)
Gross profit
$9.3b (FY, 2016)
Gross profit
$19.8b (FY, 2016)
Gross profit
€26.5b (FY, 2016)
Gross profit
N/A
Net income
Net income
Fr.9.1b (FY, 2015)
Net income
$1.4b (FY, 2016)
Net income
$7.2b (FY, 2016)
Net income
$2.6b (FY, 2016)
Net income
$6b (FY, 2016)
Net income
€4.5b (FY, 2016)
Net income
N/A

Operating

Countries
Countries
N/A
Countries
N/A
Countries
N/A
Countries
60 (FY, 2016)
Countries
N/A
Countries
152 (FY, 2016)
Countries
N/A
Drugs Approved by FDA
Drugs Approved by FDA
2 (Y, 2015)
Drugs Approved by FDA
N/A
Drugs Approved by FDA
1 (Y, 2015)
Drugs Approved by FDA
N/A
Drugs Approved by FDA
N/A
Drugs Approved by FDA
N/A
Drugs Approved by FDA
N/A
Phase III Trials
Phase III Trials
N/A
Phase III Trials
N/A
Phase III Trials
34 (Y, 2016)
Phase III Trials
N/A
Phase III Trials
N/A
Phase III Trials
17 (FY, 2015)
Phase III Trials
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles